Recombinant Streptomyces hygroscopicus host cells that produce 17-desmethylrapamycin
US6670168B1 · kind B1 · utility
13Cited by
6References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2000 |
| Grant date | Dec 30, 2003 |
| Priority date | — |
| Expiry date | Jan 20, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12P17/188
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Recombinant host cells that produce rapamycin analogues are constructed by deleting or modifying rapamycin biosynthetic gene cluster genes and are useful in the production of compounds used as antifungals, anticancers, immunosuppressants, and neurotrophins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.